Literature DB >> 22644369

Antithrombotic therapy in patients with chronic kidney disease.

Davide Capodanno1, Dominick J Angiolillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22644369     DOI： 10.1161/CIRCULATIONAHA.111.084996

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  31 in total

1.  Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off.

Authors:  Matthias Bossard; Raban Jeger
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Xuan Cai; Jungwha Lee; Julia J Scialla; Nisha Bansal; James H Sondheimer; Jing Chen; L Lee Hamm; Ana C Ricardo; Sankar D Navaneethan; Rajat Deo; Mahboob Rahman; Harold I Feldman; Alan S Go; Tamara Isakova; Myles Wolf
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

3.  Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data.

Authors:  Luca Di Lullo; Giovanni Tripepi; Claudio Ronco; Antonio De Pascalis; Vincenzo Barbera; Antonio Granata; Domenico Russo; Biagio Raffaele Di Iorio; Ernesto Paoletti; Maura Ravera; Maria Fusaro; Antonio Bellasi
Journal:  J Nephrol       Date:  2018-06-07       Impact factor: 3.902

4.  Paroxysmal Atrial Fibrillation in a Patient on Hemodialysis.

Authors:  Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-09       Impact factor: 8.237

5.  Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome.

Authors:  Anna Toso; Stefano De Servi; Mario Leoncini; Dominick J Angiolillo; Paolo Calabrò; Federico Piscione; Marco Cattaneo; Diego Maffeo; Antonio Bartorelli; Cataldo Palmieri; Marco De Carlo; Davide Capodanno; Philippe Genereux; Francesco Bellandi; Chiara Barozzi; Luciana Tomasi; Diego Della Riva; Tullio Palmerini
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

6.  Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.

Authors:  Megan V Yanik; Marguerite R Irvin; T Mark Beasley; Pamala A Jacobson; Bruce A Julian; Nita A Limdi
Journal:  Pharmacotherapy       Date:  2017-11-02       Impact factor: 4.705

7.  Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus.

Authors:  Antonio Tello-Montoliu; Jose Luis Ferreiro; Murali K Kodali; Masafumi Ueno; Salvatore D Tomasello; Fabiana Rollini; Davide Capodanno; Andrew Darlington; Ronakkumar Patel; Bhaloo Desai; Luis A Guzman; Theodore A Bass; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

8.  Evaluating safety of thrombolysis in chronic kidney disease patients presenting with pulmonary embolism using propensity score matching.

Authors:  Brijesh Patel; Naveen Sablani; Mahek Shah; Lohit Garg; Manyoo Agarwal; Sahil Agrawal; Susan Steigerwalt; Raman Dusaj
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

9.  Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia.

Authors:  Semira Abdi Beshir; Kok-Han Chee; Yoke-Lin Lo
Journal:  Int J Clin Pharm       Date:  2016-07-23

10.  Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.

Authors:  A Y Mehta; B M Mohammed; E J Martin; D F Brophy; D Gailani; U R Desai
Journal:  J Thromb Haemost       Date:  2016-02-16       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.